Endocrine Reviews 20 (3): 345-357
Copyright © 1999 by The Endocrine Society
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
Tatsuo Suda,
Naoyuki Takahashi,
Nobuyuki Udagawa,
Eijiro Jimi,
Matthew T. Gillespie and
T. John Martin
Department of Biochemistry (T.S., N.T., N.U., E.J.), School of
Dentistry, Showa University, Shinagawa-ku, Tokyo 142-8555,
Japan; and St. Vincents Institute of Medical Research (M.T.G.,
T.J.M.), University of Melbourne, Fitzroy, Victoria 3065,
Australia
- I. Introduction
- II. Role of Osteoblasts/Stromal Cells in Osteoclast Differentiation and
Function
- A. Origin of osteoclasts
- B. Stimulation of osteoclast differentiation by osteoblasts/stromal cells
- C. Stimulation of osteoclast function by osteoblasts/stromal cells
- III. New Members of the Tumor Necrosis Factor (TNF) Receptor and Ligand
Families
- A. Osteoprotegerin (OPG)
- B. Osteoclast differentiation factor (ODF) and stromal osteoclast-forming
activity (SOFA)
- IV. Regulatory Mechanism in Osteoclast Development and Function
- A. Regulatory mechanism of osteoclast differentiation by RANKL
- B. Regulatory mechanism of RANKL action on osteoclast function
- C. Signals induced by interleukin-1 (IL-1) and RANKL in osteoclasts
- V. Regulation of Human Osteoclast Development
- VI. Summary and Conclusion
Copyright © 1999 by The Endocrine Society